A hybrid, effectiveness-implementation research study protocol targeting antenatal care providers to provide female genital mutilation prevention and care services in Guinea, Kenya and Somalia.
Antenatal care providers
Female genital mutilation
Guinea
Health-sector involvement
Kenya
Person-Centred communication
Prevention
Somalia
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
01 Feb 2021
01 Feb 2021
Historique:
received:
13
07
2020
accepted:
18
01
2021
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
15
5
2021
Statut:
epublish
Résumé
In settings with high prevalence of female genital mutilation (FGM), the health sector could play a bigger role in its prevention and care of women and girls who have undergone this harmful practice. However, ministries of health lack clear policies, strategic plans or dedicated funding to implement anti-FGM interventions. Along with limited relevant knowledge and skills to prevent the practice of FGM and care for girls and women living with FGM, health providers have limited interpersonal communication skills and self-efficacy, while some may have supportive attitudes towards FGM and its medicalization. We propose to test the effectiveness of a health system strengthening intervention that includes training antenatal care (ANC) providers on person-centred communication (PCC) for FGM prevention. This will be a two-level, hybrid, effectiveness-implementation research study using a cluster randomized trial design in Guinea, Kenya and Somalia conducted over a 6 months period. In each country, within pre-selected regions/counties, 60 ANC clinics will be randomized to intervention and control arms. At baseline, all clinics will receive the level one intervention involving provision of FGM-related clinical guidelines and handbook as well as anti-FGM policies and posters. At month 3, intervention clinics will receive the level two intervention comprising of a training for ANC providers on PCC to challenge their FGM-related attitudes and build their communication skills to effectively provide FGM prevention counselling. A process evaluation will be conducted to understand 'how' and 'why' the intervention package achieves intended results. Multi-level regression modelling will be used for quantitative data analysis while qualitative data will be assessed using thematic content analysis to determine the effectiveness, feasibility and acceptability of the different intervention levels. The proposed study will strengthen the knowledge base regarding how to effectively involve health providers in FGM prevention and care. Trial registration and date: PACTR201906696419769 (June 3rd, 2019).
Sections du résumé
BACKGROUND
BACKGROUND
In settings with high prevalence of female genital mutilation (FGM), the health sector could play a bigger role in its prevention and care of women and girls who have undergone this harmful practice. However, ministries of health lack clear policies, strategic plans or dedicated funding to implement anti-FGM interventions. Along with limited relevant knowledge and skills to prevent the practice of FGM and care for girls and women living with FGM, health providers have limited interpersonal communication skills and self-efficacy, while some may have supportive attitudes towards FGM and its medicalization. We propose to test the effectiveness of a health system strengthening intervention that includes training antenatal care (ANC) providers on person-centred communication (PCC) for FGM prevention.
METHODS
METHODS
This will be a two-level, hybrid, effectiveness-implementation research study using a cluster randomized trial design in Guinea, Kenya and Somalia conducted over a 6 months period. In each country, within pre-selected regions/counties, 60 ANC clinics will be randomized to intervention and control arms. At baseline, all clinics will receive the level one intervention involving provision of FGM-related clinical guidelines and handbook as well as anti-FGM policies and posters. At month 3, intervention clinics will receive the level two intervention comprising of a training for ANC providers on PCC to challenge their FGM-related attitudes and build their communication skills to effectively provide FGM prevention counselling. A process evaluation will be conducted to understand 'how' and 'why' the intervention package achieves intended results. Multi-level regression modelling will be used for quantitative data analysis while qualitative data will be assessed using thematic content analysis to determine the effectiveness, feasibility and acceptability of the different intervention levels.
DISCUSSION
CONCLUSIONS
The proposed study will strengthen the knowledge base regarding how to effectively involve health providers in FGM prevention and care.
TRIAL REGISTRATION
BACKGROUND
Trial registration and date: PACTR201906696419769 (June 3rd, 2019).
Identifiants
pubmed: 33522926
doi: 10.1186/s12913-021-06097-w
pii: 10.1186/s12913-021-06097-w
pmc: PMC7848669
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
J Adolesc Health. 2019 Dec;65(6S):S16-S40
pubmed: 31761001
Reprod Health. 2017 May 22;14(1):64
pubmed: 28532515
Stud Fam Plann. 2012 Jun;43(2):135-46
pubmed: 23175952
Soc Sci Med. 2005 Oct;61(7):1516-28
pubmed: 16005784
J Midwifery Womens Health. 2013 Jul-Aug;58(4):451-6
pubmed: 23931662
J Am Board Fam Med. 2014 Sep-Oct;27(5):621-36
pubmed: 25201932
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
J Adv Nurs. 2016 Feb;72(2):245-60
pubmed: 26434563
PLoS One. 2019 Mar 12;14(3):e0213380
pubmed: 30861029
Obstet Gynecol Int. 2013;2013:348248
pubmed: 23737795
Cochrane Database Syst Rev. 2017 Sep 12;9:CD011086
pubmed: 28895659
J Clin Nurs. 2013 Feb;22(3-4):456-65
pubmed: 23231540
J Contin Educ Health Prof. 2012 Spring;32(2):90-7
pubmed: 22733636
BMC Health Serv Res. 2018 Apr 4;18(1):240
pubmed: 29615033
Learn Health Syst. 2019 Sep 26;4(1):e10201
pubmed: 31989028
Psychosom Med. 1998 May-Jun;60(3):268-76
pubmed: 9625213
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509